Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference0.5%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.4%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.0%
- Check51 days agoChange DetectedA new study publication on the efficacy of Pembrolizumab as adjuvant therapy for melanoma has been added, while several older entries from February 2024 have been removed.SummaryDifference2%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.